Omega Diagnostics (#ODX) – confirms discounted fundraise discussions per “online speculation”, it means per @tomwinnifrith @shareprophets

BREAKING: Omega Diagnostics, hugely discounted placing next week – source

As its CEO "was resigned" on 19 January Omega Diagnostics (ODX) poured cold water on the suggestion that it was about to do a bailout placing in a way that I said was grossly misleading HERE. Well knock me down with a feather.

Omega Diagnostics manifestly deceives investors as CEO walks the plank

If the share price of a company is in sharp decline and the CEO walks it is for one of two reasons and neither is good. It could be that the CEO knows that things can only get worse and wants to put as much clear blue water between him and a ship that is bound to sink. Or the rest of the board know that stakeholders will only do what is needed to try to keep the ship afloat if there is a change of captain, it is an admission that the ship is in deep trouble. Either way it is always a sign to sell or short or add to shorts and that brings me to Omega Diagnostics (ODX) where I have been a long term bear.

Omega Diagnostics – how close to tits up? Placing process surely now underway - Why not ‘fess up?

You do not need the brains of, the amazing, Rachel Riley to work out that Omega Diagnostics (ODX) needs to do a placing PDQ or it is in serious danger of going tits up, But for those Bulletin Board Morons who, having the brains of a park bench, are in denial here are the maths:

Omega Diagnostics hit with a £2.5 million bill after the government terminates its contract

The last time I wrote about Omega Diagnostics (ODX) was back in June when I got slated for suggesting that the company had missed the boat when it came to Covid testing, and that its Department of Health and Social Care contract wasn’t worth the headline figure you so often saw people banging on about!

Meet Craig Inglis – a moronic Saltire flying Scottish troll from LinkedIn

Craig Inglis used to be a soccer referee and before that he was manager of the Raith Rovers supporters club. You can see his profile here. He is now apparently a full-time investor. I suggest he is a moron. He asked to “connect with me” two weeks ago and last night I accepted his offer. Quick as a flash this morning he has pinged me and we have had the following exchange. Where do these morons come from?

Will Covid testing be around long enough for companies like Omega Diagnostics to justify their valuations? I doubt it!

I’ve recently found myself wondering how many of these ‘Covid stocks’ have missed the boat, as many of them still aren’t producing any significant amounts of revenue, yet often their markets caps are comparatively very high.

Omega Diagnostics (#ODX) – CE-Mark of Mologic COVID-19 lateral flow antigen test

Omega Diagnostics (#ODX) – expects EBITDA loss of £2.1m-£2.3m, though new contract to significantly benefit next year

Here's A Covid-Testing Outfit that Could Still Be Worth a Look

Hello Share Chasers. The share price of Avacta (AVCT) shares is holding up rather well, considering that vaccines will soon render the virus far less common. Perhaps the world expects testing to be needed until the virus disappears altogether. And we all know that's unlikely. So, if Avacta shares continue to do well, perhaps we could consider another company which also has some news on the testing front...

Omega Diagnostics (#ODX) – open offer excess applications to be scaled back

Omega Diagnostics (#ODX) – raises £634,795 at 10p

Omega Diagnostics (#ODX) – headwinds have continued, refocusing & reducing cost base

Zak Mir's Bull Call of the Day No. 2: Omega Diagnostics: Above 200 Day Line Targets 25p Plus

Although it may appear that Omega Diagnostics shares have not been up to much of late, at least it can be said from a technical perspective that the lack of relative news has been good news.

Omega Diagnostics (#ODX) - pretty upbeat H1 trading statement